PCR Based Transplant Diagnostics Market Likely to Surpass USD 1.1 Billion by 2035

Global PCR Based Transplant Diagnostics Market Forecast 2035:

According to the report, the global PCR based transplant diagnostics market is projected to expand from USD 0.5 billion in 2025 to USD 1.1 billion by 2035, registering a CAGR of 7.8%, the highest during the forecast period. The increase in the focus on personalized medicine and precision healthcare is the PCR based transplant diagnostics market that leads to the rise of the demand of personalized transplant monitoring solutions. For instance, in 2025, Illumina introduced its TruSight Transplant Monitoring Solution that allows clinicians to monitor donor-derived cell-free DNA with high precision to provide highly personalized post-transplant care. This trend is influencing the incorporation of the new high diagnostics, which enhances patient-specific outcomes and long graft survival.

Additionally, the rising government efforts and investments to promote organ transplantation and improved diagnostic technologies are the growing PCR-based transplant diagnostics market. For instance, in 2024, the U.S Department of Health and Human Services (HHS) was able to grant funds to facilitate the implementation of molecular-based transplant monitoring programs within large medical facilities, which facilitates an increase in the use of PCR diagnostics. These governmental interventions have been boosting market development by increasing access to sophisticated transplant monitoring and the overall patient outcomes.

“Key Driver, Restraint, and Growth Opportunity Shaping the Global PCR Based Transplant Diagnostics Market”

The change in non-invasive monitoring to biomarkers of donor-derived cell-free DNA and viral nucleic acids is driving the PCr-based transplant diagnostics market. Such methods minimize invasive-based biopsies, minimize patient risk and allow the real-time and continuous evaluation of the health of transplants. For instance, the Prospera assay by Natera is a non-invasive, PCR based technique to monitor kidney transplant rejection, which has proved to be better in-patient compliance and quicker in clinical decision making. This driver will lead to increased patient safety, encouragement of the use of PCR diagnostics, and more proactive clinical management of transplant outcomes.

The implementation of PCR-based transplant diagnostics is limited by the lack of doctor-level molecular diagnostics specialists who can run advanced PCR platforms and interpret the complicated information. The high level of training needed and the complexity of operations may delay the implementation in smaller or resource constrained healthcare facilities. This restriction can delay the growth of the market because people will not be able to receive high-quality PCR diagnostics in some regions or facilities.

The growing popularity of telemedicine and remote monitoring in the medical field offers PCR-based transplant diagnostics an opportunity to offer real-time data to remotely assess clinical conditions. Digital health platforms can be combined with PCR tests to monitor the level of biomarkers and notify clinicians about precursors of graft complications. This would increase market coverage, enhance patient convenience, and facilitate individualized and continuous transplant care in a variety of health care locations.

Expansion of Global PCR Based Transplant Diagnostics Market

“Expansion of Multi-Organ Transplant Monitoring Solutions”

The growth in the multi-organ transplant monitoring solutions is fueling the PCR based transplant diagnostics market to allow simultaneous evaluation of kidney, liver, and heart, and lung transplants with only one platform. The methodology enhances the efficiency of the working process, decreases the duration of testing, and gives a detailed understanding of the patient, enabling clinicians to identify the rejection or complications at an earlier stage and properly target multiple organ interventions.
These an expansion improves the efficiency and outcomes of clinical processes and patient outcomes as it allows monitoring of multi-organ transplants faster, comprehensively, and more accurately.

Regional Analysis of Global PCR Based Transplant Diagnostics Market

The demand is highest in North America due to the region’s strong regulatory support for molecular diagnostics, high healthcare spending, and rapid clinical adoption of precision medicine in transplant care. The high-level laboratory facilities provide the routine implementation of PCR tests to monitor infections and track rejections.
In 2024, Roche increased the clinical application of its cobas PCR systems in the U.S. transplant centers, which will facilitate standardized and high-throughput post-transplant tests. The leadership in North America promotes the use of innovation and clinical standards in transplant diagnostics at a global level.
Asia Pacific is witnessing strong growth due to increasing organ transplant volumes, expanding healthcare infrastructure, and rising government investment in advanced diagnostics. Countries such as China, India, and Japan are strengthening molecular testing capabilities to address growing transplant needs and improve long-term patient outcomes.

Prominent players operating in the global PCR based transplant diagnostics market are Abbott Laboratories, Agilent Technologies, bioMérieux, Bio-Rad Laboratories, CareDx, Eurofins Scientific, GenDx, Genetix Biotech Asia, Histogenetics, Hologic, Illumina, Immucor, Integrated DNA Technologies (IDT), Linkage Biosciences, Luminex Corporation, Natera, Olerup SSP, Promega Corporation, Qiagen, Roche Diagnostics, Takara Bio, Thermo Fisher Scientific, and Other Key Players.

The global PCR based transplant diagnostics market has been segmented as follows:

Global PCR Based Transplant Diagnostics Market Analysis, By Technology Type

Quantitative Real-Time PCR (qPCR)
- TaqMan-based qPCR
- SYBR Green-based qPCR
- Molecular Beacon-based qPCR
Digital PCR (dPCR)
- Droplet Digital PCR (ddPCR)
- Chip-based Digital PCR
Multiplex PCR
- Standard Multiplex PCR
- Nested Multiplex PCR
Reverse Transcription PCR (RT-PCR)
Allele-Specific PCR
Hot Start PCR

Global PCR Based Transplant Diagnostics Market Analysis, By Application

Pre-Transplant Screening
- Donor Screening
- Recipient Screening
- HLA Typing
- Infectious Disease Testing
- Others
Post-Transplant Monitoring
- Rejection Monitoring
- Chimerism Analysis
- Viral Load Monitoring
- Minimal Residual Disease Detection
- Others
Infectious Disease Detection
- CMV Detection
- EBV Detection
- BK Virus Detection
- Adenovirus Detection
- HIV Detection
- HBV Detection
- HCV Detection
- Others

Global PCR Based Transplant Diagnostics Market Analysis, By Transplant Type

Solid Organ Transplantation
- Kidney Transplant
- Liver Transplant
- Heart Transplant
- Lung Transplant
- Pancreas Transplant
- Others
Hematopoietic Stem Cell Transplantation (HSCT)
- Allogeneic HSCT
- Autologous HSCT
Tissue Transplantation

Global PCR Based Transplant Diagnostics Market Analysis, By Sample Type

Blood Samples
- Whole Blood
- Plasma
- Serum
- Peripheral Blood Mononuclear Cells (PBMCs)
- Others
Tissue Biopsy
Urine Samples
Saliva Samples
Bone Marrow Samples
Others

Global PCR Based Transplant Diagnostics Market Analysis, By Product Type

Reagents & Consumables
- PCR Master Mixes
- Primers & Probes
- DNA/RNA Extraction Kits
- PCR Plates & Tubes
- Enzyme Mixes
- Others
Instruments & Systems
- Thermal Cyclers
- Real-Time PCR Systems
- Digital PCR Systems
- Automated Extraction Systems
- Others
Software & Services
- Data Analysis Software
- Laboratory Information Management Systems (LIMS)
- Testing Services
- Maintenance Services
- Others

Global PCR Based Transplant Diagnostics Market Analysis, By End-User

Hospitals & Transplant Centers
- Academic Medical Centers
- Community Hospitals
- Specialty Transplant Centers
Diagnostic Laboratories
- Independent Reference Laboratories
- Hospital-based Laboratories
- Specialty Diagnostic Centers
Research & Academic Institutes
- University Research Centers
- Government Research Facilities
- Private Research Organizations
Blood Banks
Contract Research Organizations (CROs)

Global PCR Based Transplant Diagnostics Market Analysis, By Testing Location

In-house Testing
Reference Laboratory Testing
Point-of-Care Testing

Global PCR Based Transplant Diagnostics Market Analysis, By Region

North America
Europe
Asia Pacific
Middle East
Africa
South America

About Us

MarketGenics is a global market research and management consulting company empowering decision makers from startups, Fortune 500 companies, non-profit organizations, universities and government institutions. Our main goal is to assist and partner organizations to make lasting strategic improvements and realize growth targets. Our industry research reports are designed to provide granular quantitative information, combined with key industry insights, aimed at assisting sustainable organizational development.

We serve clients on every aspect of strategy, including product development, application modeling, exploring new markets and tapping into niche growth opportunities.

Contact Us

USA Address:

800 N King Street Suite 304 #4208 Wilmington, DE 19801 United States.

+1(302)303-2617

info@marketgenics.co

India Address:

3rd floor, Indeco Equinox, Baner Road, Baner, Pune, Maharashtra 411045 India.

sales@marketgenics.co

Table of Contents

1. Research Methodology and Assumptions
- 1.1. Definitions
- 1.2. Research Design and Approach
- 1.3. Data Collection Methods
- 1.4. Base Estimates and Calculations
- 1.5. Forecasting Models
  - 1.5.1. Key Forecast Factors & Impact Analysis
- 1.6. Secondary Research
  - 1.6.1. Open Sources
  - 1.6.2. Paid Databases
  - 1.6.3. Associations
- 1.7. Primary Research
  - 1.7.1. Primary Sources
  - 1.7.2. Primary Interviews with Stakeholders across Ecosystem
2. Executive Summary
- 2.1. Global PCR Based Transplant Diagnostics Market Outlook
  - 2.1.1. PCR Based Transplant Diagnostics Market Size (Value - US$ Bn), and Forecasts, 2021-2035
  - 2.1.2. Compounded Annual Growth Rate Analysis
  - 2.1.3. Growth Opportunity Analysis
  - 2.1.4. Segmental Share Analysis
  - 2.1.5. Geographical Share Analysis
- 2.2. Market Analysis and Facts
- 2.3. Supply-Demand Analysis
- 2.4. Competitive Benchmarking
- 2.5. Go-to- Market Strategy
  - 2.5.1. Customer/ End-use Industry Assessment
  - 2.5.2. Growth Opportunity Data, 2026-2035
    - 2.5.2.1. Regional Data
    - 2.5.2.2. Country Data
    - 2.5.2.3. Segmental Data
  - 2.5.3. Identification of Potential Market Spaces
  - 2.5.4. GAP Analysis
  - 2.5.5. Potential Attractive Price Points
  - 2.5.6. Prevailing Market Risks & Challenges
  - 2.5.7. Preferred Sales & Marketing Strategies
  - 2.5.8. Key Recommendations and Analysis
  - 2.5.9. A Way Forward
3. Industry Data and Premium Insights
- 3.1. Global Healthcare & Pharmaceutical Industry Overview, 2025
  - 3.1.1. Healthcare & Pharmaceutical Ecosystem Analysis
  - 3.1.2. Key Trends for Healthcare & Pharmaceutical Industry
  - 3.1.3. Regional Distribution for Healthcare & Pharmaceutical Industry
- 3.2. Supplier Customer Data
- 3.3. Technology Roadmap and Developments
- 3.4. Trade Analysis
  - 3.4.1. Import & Export Analysis, 2025
  - 3.4.2. Top Importing Countries
  - 3.4.3. Top Exporting Countries
- 3.5. Trump Tariff Impact Analysis
  - 3.5.1. Manufacturer
    - 3.5.1.1. Based on the component & Raw material
  - 3.5.2. Supply Chain
  - 3.5.3. End Consumer
- 3.6. Raw Material Analysis
4. Market Overview
- 4.1. Market Dynamics
  - 4.1.1. Drivers
    - 4.1.1.1. Rising organ transplant procedures driven by increasing chronic diseases and organ failure cases
    - 4.1.1.2. Technological advancements in PCR assays enabling faster, more accurate donor–recipient matching
    - 4.1.1.3. Growing adoption of molecular diagnostics for transplant compatibility and rejection monitoring
  - 4.1.2. Restraints
    - 4.1.2.1. High cost of PCR-based transplant diagnostic tests and limited reimbursement
    - 4.1.2.2. Shortage of skilled professionals and limited access to advanced diagnostic infrastructure
- 4.2. Key Trend Analysis
- 4.3. Regulatory Framework
  - 4.3.1. Key Regulations, Norms, and Subsidies, by Key Countries
  - 4.3.2. Tariffs and Standards
  - 4.3.3. Impact Analysis of Regulations on the Market
- 4.4. Value Chain Analysis
  - 4.4.1. PCR Instrument & Reagent Suppliers
  - 4.4.2. Diagnostic Kit Manufacturers
  - 4.4.3. Distribution & Logistics
  - 4.4.4. Hospitals & Transplant Clinics
- 4.5. Porter’s Five Forces Analysis
- 4.6. PESTEL Analysis
- 4.7. Global PCR Based Transplant Diagnostics Market Demand
  - 4.7.1. Historical Market Size – Value (US$ Bn), 2020-2024
  - 4.7.2. Current and Future Market Size – Value (US$ Bn), 2026–2035
    - 4.7.2.1. Y-o-Y Growth Trends
    - 4.7.2.2. Absolute $ Opportunity Assessment
5. Competition Landscape
- 5.1. Competition structure
  - 5.1.1. Fragmented v/s consolidated
- 5.2. Company Share Analysis, 2025
  - 5.2.1. Global Company Market Share
  - 5.2.2. By Region
    - 5.2.2.1. North America
    - 5.2.2.2. Europe
    - 5.2.2.3. Asia Pacific
    - 5.2.2.4. Middle East
    - 5.2.2.5. Africa
    - 5.2.2.6. South America
- 5.3. Product Comparison Matrix
  - 5.3.1. Specifications
  - 5.3.2. Market Positioning
  - 5.3.3. Pricing
6. Global PCR Based Transplant Diagnostics Market Analysis, by Technology Type
- 6.1. Key Segment Analysis
- 6.2. PCR Based Transplant Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, by Technology Type, 2021-2035
  - 6.2.1. Quantitative Real-Time PCR (qPCR)
    - 6.2.1.1. TaqMan-based qPCR
    - 6.2.1.2. SYBR Green-based qPCR
    - 6.2.1.3. Molecular Beacon-based qPCR
  - 6.2.2. Digital PCR (dPCR)
    - 6.2.2.1. Droplet Digital PCR (ddPCR)
    - 6.2.2.2. Chip-based Digital PCR
  - 6.2.3. Multiplex PCR
    - 6.2.3.1. Standard Multiplex PCR
    - 6.2.3.2. Nested Multiplex PCR
  - 6.2.4. Reverse Transcription PCR (RT-PCR)
  - 6.2.5. Allele-Specific PCR
  - 6.2.6. Hot Start PCR
7. Global PCR Based Transplant Diagnostics Market Analysis, by Application
- 7.1. Key Segment Analysis
- 7.2. PCR Based Transplant Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, by Application, 2021-2035
  - 7.2.1. Pre-Transplant Screening
    - 7.2.1.1. Donor Screening
    - 7.2.1.2. Recipient Screening
    - 7.2.1.3. HLA Typing
    - 7.2.1.4. Infectious Disease Testing
    - 7.2.1.5. Others
  - 7.2.2. Post-Transplant Monitoring
    - 7.2.2.1. Rejection Monitoring
    - 7.2.2.2. Chimerism Analysis
    - 7.2.2.3. Viral Load Monitoring
    - 7.2.2.4. Minimal Residual Disease Detection
    - 7.2.2.5. Others
  - 7.2.3. Infectious Disease Detection
    - 7.2.3.1. CMV Detection
    - 7.2.3.2. EBV Detection
    - 7.2.3.3. BK Virus Detection
    - 7.2.3.4. Adenovirus Detection
    - 7.2.3.5. HIV Detection
    - 7.2.3.6. HBV Detection
    - 7.2.3.7. HCV Detection
    - 7.2.3.8. Others
8. Global PCR Based Transplant Diagnostics Market Analysis, by Transplant Type
- 8.1. Key Segment Analysis
- 8.2. PCR Based Transplant Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, by Transplant Type, 2021-2035
  - 8.2.1. Solid Organ Transplantation
    - 8.2.1.1. Kidney Transplant
    - 8.2.1.2. Liver Transplant
    - 8.2.1.3. Heart Transplant
    - 8.2.1.4. Lung Transplant
    - 8.2.1.5. Pancreas Transplant
    - 8.2.1.6. Others
  - 8.2.2. Hematopoietic Stem Cell Transplantation (HSCT)
    - 8.2.2.1. Allogeneic HSCT
    - 8.2.2.2. Autologous HSCT
  - 8.2.3. Tissue Transplantation
9. Global PCR Based Transplant Diagnostics Market Analysis, by Sample Type
- 9.1. Key Segment Analysis
- 9.2. PCR Based Transplant Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, by Sample Type, 2021-2035
  - 9.2.1. Blood Samples
    - 9.2.1.1. Whole Blood
    - 9.2.1.2. Plasma
    - 9.2.1.3. Serum
    - 9.2.1.4. Peripheral Blood Mononuclear Cells (PBMCs)
    - 9.2.1.5. Others
  - 9.2.2. Tissue Biopsy
  - 9.2.3. Urine Samples
  - 9.2.4. Saliva Samples
  - 9.2.5. Bone Marrow Samples
  - 9.2.6. Others
10. Global PCR Based Transplant Diagnostics Market Analysis, by Product Type
- 10.1. Key Segment Analysis
- 10.2. PCR Based Transplant Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, by Product Type, 2021-2035
  - 10.2.1. Reagents & Consumables
    - 10.2.1.1. PCR Master Mixes
    - 10.2.1.2. Primers & Probes
    - 10.2.1.3. DNA/RNA Extraction Kits
    - 10.2.1.4. PCR Plates & Tubes
    - 10.2.1.5. Enzyme Mixes
    - 10.2.1.6. Others
  - 10.2.2. Instruments & Systems
    - 10.2.2.1. Thermal Cyclers
    - 10.2.2.2. Real-Time PCR Systems
    - 10.2.2.3. Digital PCR Systems
    - 10.2.2.4. Automated Extraction Systems
    - 10.2.2.5. Others
  - 10.2.3. Software & Services
    - 10.2.3.1. Data Analysis Software
    - 10.2.3.2. Laboratory Information Management Systems (LIMS)
    - 10.2.3.3. Testing Services
    - 10.2.3.4. Maintenance Services
    - 10.2.3.5. Others
11. Global PCR Based Transplant Diagnostics Market Analysis, by End-User
- 11.1. Key Segment Analysis
- 11.2. PCR Based Transplant Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, by End-User, 2021-2035
  - 11.2.1. Hospitals & Transplant Centers
    - 11.2.1.1. Academic Medical Centers
    - 11.2.1.2. Community Hospitals
    - 11.2.1.3. Specialty Transplant Centers
  - 11.2.2. Diagnostic Laboratories
    - 11.2.2.1. Independent Reference Laboratories
    - 11.2.2.2. Hospital-based Laboratories
    - 11.2.2.3. Specialty Diagnostic Centers
  - 11.2.3. Research & Academic Institutes
    - 11.2.3.1. University Research Centers
    - 11.2.3.2. Government Research Facilities
    - 11.2.3.3. Private Research Organizations
  - 11.2.4. Blood Banks
  - 11.2.5. Contract Research Organizations (CROs)
12. Global PCR Based Transplant Diagnostics Market Analysis and Forecasts, by Testing Location
- 12.1. Key Findings
- 12.2. PCR Based Transplant Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, by Testing Location, 2021-2035
  - 12.2.1. In-house Testing
  - 12.2.2. Reference Laboratory Testing
  - 12.2.3. Point-of-Care Testing
13. Global PCR Based Transplant Diagnostics Market Analysis and Forecasts, by Region
- 13.1. Key Findings
- 13.2. PCR Based Transplant Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, by Region, 2021-2035
  - 13.2.1. North America
  - 13.2.2. Europe
  - 13.2.3. Asia Pacific
  - 13.2.4. Middle East
  - 13.2.5. Africa
  - 13.2.6. South America
14. North America PCR Based Transplant Diagnostics Market Analysis
- 14.1. Key Segment Analysis
- 14.2. Regional Snapshot
- 14.3. North America PCR Based Transplant Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 14.3.1. Technology Type
  - 14.3.2. Application
  - 14.3.3. Transplant Type
  - 14.3.4. Sample Type
  - 14.3.5. Product Type
  - 14.3.6. End-User
  - 14.3.7. Testing Location
  - 14.3.8. Country
    - 14.3.8.1. USA
    - 14.3.8.2. Canada
    - 14.3.8.3. Mexico
- 14.4. USA PCR Based Transplant Diagnostics Market
  - 14.4.1. Country Segmental Analysis
  - 14.4.2. Technology Type
  - 14.4.3. Application
  - 14.4.4. Transplant Type
  - 14.4.5. Sample Type
  - 14.4.6. Product Type
  - 14.4.7. End-User
  - 14.4.8. Testing Location
- 14.5. Canada PCR Based Transplant Diagnostics Market
  - 14.5.1. Country Segmental Analysis
  - 14.5.2. Technology Type
  - 14.5.3. Application
  - 14.5.4. Transplant Type
  - 14.5.5. Sample Type
  - 14.5.6. Product Type
  - 14.5.7. End-User
  - 14.5.8. Testing Location
- 14.6. Mexico PCR Based Transplant Diagnostics Market
  - 14.6.1. Country Segmental Analysis
  - 14.6.2. Technology Type
  - 14.6.3. Application
  - 14.6.4. Transplant Type
  - 14.6.5. Sample Type
  - 14.6.6. Product Type
  - 14.6.7. End-User
  - 14.6.8. Testing Location
15. Europe PCR Based Transplant Diagnostics Market Analysis
- 15.1. Key Segment Analysis
- 15.2. Regional Snapshot
- 15.3. Europe PCR Based Transplant Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 15.3.1. Technology Type
  - 15.3.2. Application
  - 15.3.3. Transplant Type
  - 15.3.4. Sample Type
  - 15.3.5. Product Type
  - 15.3.6. End-User
  - 15.3.7. Testing Location
  - 15.3.8. Country
    - 15.3.8.1. Germany
    - 15.3.8.2. United Kingdom
    - 15.3.8.3. France
    - 15.3.8.4. Italy
    - 15.3.8.5. Spain
    - 15.3.8.6. Netherlands
    - 15.3.8.7. Nordic Countries
    - 15.3.8.8. Poland
    - 15.3.8.9. Russia & CIS
    - 15.3.8.10. Rest of Europe
- 15.4. Germany PCR Based Transplant Diagnostics Market
  - 15.4.1. Country Segmental Analysis
  - 15.4.2. Technology Type
  - 15.4.3. Application
  - 15.4.4. Transplant Type
  - 15.4.5. Sample Type
  - 15.4.6. Product Type
  - 15.4.7. End-User
  - 15.4.8. Testing Location
- 15.5. United Kingdom PCR Based Transplant Diagnostics Market
  - 15.5.1. Country Segmental Analysis
  - 15.5.2. Technology Type
  - 15.5.3. Application
  - 15.5.4. Transplant Type
  - 15.5.5. Sample Type
  - 15.5.6. Product Type
  - 15.5.7. End-User
  - 15.5.8. Testing Location
- 15.6. France PCR Based Transplant Diagnostics Market
  - 15.6.1. Country Segmental Analysis
  - 15.6.2. Technology Type
  - 15.6.3. Application
  - 15.6.4. Transplant Type
  - 15.6.5. Sample Type
  - 15.6.6. Product Type
  - 15.6.7. End-User
  - 15.6.8. Testing Location
- 15.7. Italy PCR Based Transplant Diagnostics Market
  - 15.7.1. Country Segmental Analysis
  - 15.7.2. Technology Type
  - 15.7.3. Application
  - 15.7.4. Transplant Type
  - 15.7.5. Sample Type
  - 15.7.6. Product Type
  - 15.7.7. End-User
  - 15.7.8. Testing Location
- 15.8. Spain PCR Based Transplant Diagnostics Market
  - 15.8.1. Country Segmental Analysis
  - 15.8.2. Technology Type
  - 15.8.3. Application
  - 15.8.4. Transplant Type
  - 15.8.5. Sample Type
  - 15.8.6. Product Type
  - 15.8.7. End-User
  - 15.8.8. Testing Location
- 15.9. Netherlands PCR Based Transplant Diagnostics Market
  - 15.9.1. Country Segmental Analysis
  - 15.9.2. Technology Type
  - 15.9.3. Application
  - 15.9.4. Transplant Type
  - 15.9.5. Sample Type
  - 15.9.6. Product Type
  - 15.9.7. End-User
  - 15.9.8. Testing Location
- 15.10. Nordic Countries PCR Based Transplant Diagnostics Market
  - 15.10.1. Country Segmental Analysis
  - 15.10.2. Technology Type
  - 15.10.3. Application
  - 15.10.4. Transplant Type
  - 15.10.5. Sample Type
  - 15.10.6. Product Type
  - 15.10.7. End-User
  - 15.10.8. Testing Location
- 15.11. Poland PCR Based Transplant Diagnostics Market
  - 15.11.1. Country Segmental Analysis
  - 15.11.2. Technology Type
  - 15.11.3. Application
  - 15.11.4. Transplant Type
  - 15.11.5. Sample Type
  - 15.11.6. Product Type
  - 15.11.7. End-User
  - 15.11.8. Testing Location
- 15.12. Russia & CIS PCR Based Transplant Diagnostics Market
  - 15.12.1. Country Segmental Analysis
  - 15.12.2. Technology Type
  - 15.12.3. Application
  - 15.12.4. Transplant Type
  - 15.12.5. Sample Type
  - 15.12.6. Product Type
  - 15.12.7. End-User
  - 15.12.8. Testing Location
- 15.13. Rest of Europe PCR Based Transplant Diagnostics Market
  - 15.13.1. Country Segmental Analysis
  - 15.13.2. Technology Type
  - 15.13.3. Application
  - 15.13.4. Transplant Type
  - 15.13.5. Sample Type
  - 15.13.6. Product Type
  - 15.13.7. End-User
  - 15.13.8. Testing Location
16. Asia Pacific PCR Based Transplant Diagnostics Market Analysis
- 16.1. Key Segment Analysis
- 16.2. Regional Snapshot
- 16.3. Asia Pacific PCR Based Transplant Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 16.3.1. Technology Type
  - 16.3.2. Application
  - 16.3.3. Transplant Type
  - 16.3.4. Sample Type
  - 16.3.5. Product Type
  - 16.3.6. End-User
  - 16.3.7. Testing Location
  - 16.3.8. Country
    - 16.3.8.1. China
    - 16.3.8.2. India
    - 16.3.8.3. Japan
    - 16.3.8.4. South Korea
    - 16.3.8.5. Australia and New Zealand
    - 16.3.8.6. Indonesia
    - 16.3.8.7. Malaysia
    - 16.3.8.8. Thailand
    - 16.3.8.9. Vietnam
    - 16.3.8.10. Rest of Asia Pacific
- 16.4. China PCR Based Transplant Diagnostics Market
  - 16.4.1. Country Segmental Analysis
  - 16.4.2. Technology Type
  - 16.4.3. Application
  - 16.4.4. Transplant Type
  - 16.4.5. Sample Type
  - 16.4.6. Product Type
  - 16.4.7. End-User
  - 16.4.8. Testing Location
- 16.5. India PCR Based Transplant Diagnostics Market
  - 16.5.1. Country Segmental Analysis
  - 16.5.2. Technology Type
  - 16.5.3. Application
  - 16.5.4. Transplant Type
  - 16.5.5. Sample Type
  - 16.5.6. Product Type
  - 16.5.7. End-User
  - 16.5.8. Testing Location
- 16.6. Japan PCR Based Transplant Diagnostics Market
  - 16.6.1. Country Segmental Analysis
  - 16.6.2. Technology Type
  - 16.6.3. Application
  - 16.6.4. Transplant Type
  - 16.6.5. Sample Type
  - 16.6.6. Product Type
  - 16.6.7. End-User
  - 16.6.8. Testing Location
- 16.7. South Korea PCR Based Transplant Diagnostics Market
  - 16.7.1. Country Segmental Analysis
  - 16.7.2. Technology Type
  - 16.7.3. Application
  - 16.7.4. Transplant Type
  - 16.7.5. Sample Type
  - 16.7.6. Product Type
  - 16.7.7. End-User
  - 16.7.8. Testing Location
- 16.8. Australia and New Zealand PCR Based Transplant Diagnostics Market
  - 16.8.1. Country Segmental Analysis
  - 16.8.2. Technology Type
  - 16.8.3. Application
  - 16.8.4. Transplant Type
  - 16.8.5. Sample Type
  - 16.8.6. Product Type
  - 16.8.7. End-User
  - 16.8.8. Testing Location
- 16.9. Indonesia PCR Based Transplant Diagnostics Market
  - 16.9.1. Country Segmental Analysis
  - 16.9.2. Technology Type
  - 16.9.3. Application
  - 16.9.4. Transplant Type
  - 16.9.5. Sample Type
  - 16.9.6. Product Type
  - 16.9.7. End-User
  - 16.9.8. Testing Location
- 16.10. Malaysia PCR Based Transplant Diagnostics Market
  - 16.10.1. Country Segmental Analysis
  - 16.10.2. Technology Type
  - 16.10.3. Application
  - 16.10.4. Transplant Type
  - 16.10.5. Sample Type
  - 16.10.6. Product Type
  - 16.10.7. End-User
  - 16.10.8. Testing Location
- 16.11. Thailand PCR Based Transplant Diagnostics Market
  - 16.11.1. Country Segmental Analysis
  - 16.11.2. Technology Type
  - 16.11.3. Application
  - 16.11.4. Transplant Type
  - 16.11.5. Sample Type
  - 16.11.6. Product Type
  - 16.11.7. End-User
  - 16.11.8. Testing Location
- 16.12. Vietnam PCR Based Transplant Diagnostics Market
  - 16.12.1. Country Segmental Analysis
  - 16.12.2. Technology Type
  - 16.12.3. Application
  - 16.12.4. Transplant Type
  - 16.12.5. Sample Type
  - 16.12.6. Product Type
  - 16.12.7. End-User
  - 16.12.8. Testing Location
- 16.13. Rest of Asia Pacific PCR Based Transplant Diagnostics Market
  - 16.13.1. Country Segmental Analysis
  - 16.13.2. Technology Type
  - 16.13.3. Application
  - 16.13.4. Transplant Type
  - 16.13.5. Sample Type
  - 16.13.6. Product Type
  - 16.13.7. End-User
  - 16.13.8. Testing Location
17. Middle East PCR Based Transplant Diagnostics Market Analysis
- 17.1. Key Segment Analysis
- 17.2. Regional Snapshot
- 17.3. Middle East PCR Based Transplant Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 17.3.1. Technology Type
  - 17.3.2. Application
  - 17.3.3. Transplant Type
  - 17.3.4. Sample Type
  - 17.3.5. Product Type
  - 17.3.6. End-User
  - 17.3.7. Testing Location
  - 17.3.8. Country
    - 17.3.8.1. Turkey
    - 17.3.8.2. UAE
    - 17.3.8.3. Saudi Arabia
    - 17.3.8.4. Israel
    - 17.3.8.5. Rest of Middle East
- 17.4. Turkey PCR Based Transplant Diagnostics Market
  - 17.4.1. Country Segmental Analysis
  - 17.4.2. Technology Type
  - 17.4.3. Application
  - 17.4.4. Transplant Type
  - 17.4.5. Sample Type
  - 17.4.6. Product Type
  - 17.4.7. End-User
  - 17.4.8. Testing Location
- 17.5. UAE PCR Based Transplant Diagnostics Market
  - 17.5.1. Country Segmental Analysis
  - 17.5.2. Technology Type
  - 17.5.3. Application
  - 17.5.4. Transplant Type
  - 17.5.5. Sample Type
  - 17.5.6. Product Type
  - 17.5.7. End-User
  - 17.5.8. Testing Location
- 17.6. Saudi Arabia PCR Based Transplant Diagnostics Market
  - 17.6.1. Country Segmental Analysis
  - 17.6.2. Technology Type
  - 17.6.3. Application
  - 17.6.4. Transplant Type
  - 17.6.5. Sample Type
  - 17.6.6. Product Type
  - 17.6.7. End-User
  - 17.6.8. Testing Location
- 17.7. Israel PCR Based Transplant Diagnostics Market
  - 17.7.1. Country Segmental Analysis
  - 17.7.2. Technology Type
  - 17.7.3. Application
  - 17.7.4. Transplant Type
  - 17.7.5. Sample Type
  - 17.7.6. Product Type
  - 17.7.7. End-User
  - 17.7.8. Testing Location
- 17.8. Rest of Middle East PCR Based Transplant Diagnostics Market
  - 17.8.1. Country Segmental Analysis
  - 17.8.2. Technology Type
  - 17.8.3. Application
  - 17.8.4. Transplant Type
  - 17.8.5. Sample Type
  - 17.8.6. Product Type
  - 17.8.7. End-User
  - 17.8.8. Testing Location
18. Africa PCR Based Transplant Diagnostics Market Analysis
- 18.1. Key Segment Analysis
- 18.2. Regional Snapshot
- 18.3. Africa PCR Based Transplant Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 18.3.1. Technology Type
  - 18.3.2. Application
  - 18.3.3. Transplant Type
  - 18.3.4. Sample Type
  - 18.3.5. Product Type
  - 18.3.6. End-User
  - 18.3.7. Testing Location
  - 18.3.8. Country
    - 18.3.8.1. South Africa
    - 18.3.8.2. Egypt
    - 18.3.8.3. Nigeria
    - 18.3.8.4. Algeria
    - 18.3.8.5. Rest of Africa
- 18.4. South Africa PCR Based Transplant Diagnostics Market
  - 18.4.1. Country Segmental Analysis
  - 18.4.2. Technology Type
  - 18.4.3. Application
  - 18.4.4. Transplant Type
  - 18.4.5. Sample Type
  - 18.4.6. Product Type
  - 18.4.7. End-User
  - 18.4.8. Testing Location
- 18.5. Egypt PCR Based Transplant Diagnostics Market
  - 18.5.1. Country Segmental Analysis
  - 18.5.2. Technology Type
  - 18.5.3. Application
  - 18.5.4. Transplant Type
  - 18.5.5. Sample Type
  - 18.5.6. Product Type
  - 18.5.7. End-User
  - 18.5.8. Testing Location
- 18.6. Nigeria PCR Based Transplant Diagnostics Market
  - 18.6.1. Country Segmental Analysis
  - 18.6.2. Technology Type
  - 18.6.3. Application
  - 18.6.4. Transplant Type
  - 18.6.5. Sample Type
  - 18.6.6. Product Type
  - 18.6.7. End-User
  - 18.6.8. Testing Location
- 18.7. Algeria PCR Based Transplant Diagnostics Market
  - 18.7.1. Country Segmental Analysis
  - 18.7.2. Technology Type
  - 18.7.3. Application
  - 18.7.4. Transplant Type
  - 18.7.5. Sample Type
  - 18.7.6. Product Type
  - 18.7.7. End-User
  - 18.7.8. Testing Location
- 18.8. Rest of Africa PCR Based Transplant Diagnostics Market
  - 18.8.1. Country Segmental Analysis
  - 18.8.2. Technology Type
  - 18.8.3. Application
  - 18.8.4. Transplant Type
  - 18.8.5. Sample Type
  - 18.8.6. Product Type
  - 18.8.7. End-User
  - 18.8.8. Testing Location
19. South America PCR Based Transplant Diagnostics Market Analysis
- 19.1. Key Segment Analysis
- 19.2. Regional Snapshot
- 19.3. South America PCR Based Transplant Diagnostics Market Size (Value - US$ Bn), Analysis, and Forecasts, 2021-2035
  - 19.3.1. Technology Type
  - 19.3.2. Application
  - 19.3.3. Transplant Type
  - 19.3.4. Sample Type
  - 19.3.5. Product Type
  - 19.3.6. End-User
  - 19.3.7. Testing Location
  - 19.3.8. Country
    - 19.3.8.1. Brazil
    - 19.3.8.2. Argentina
    - 19.3.8.3. Rest of South America
- 19.4. Brazil PCR Based Transplant Diagnostics Market
  - 19.4.1. Country Segmental Analysis
  - 19.4.2. Technology Type
  - 19.4.3. Application
  - 19.4.4. Transplant Type
  - 19.4.5. Sample Type
  - 19.4.6. Product Type
  - 19.4.7. End-User
  - 19.4.8. Testing Location
- 19.5. Argentina PCR Based Transplant Diagnostics Market
  - 19.5.1. Country Segmental Analysis
  - 19.5.2. Technology Type
  - 19.5.3. Application
  - 19.5.4. Transplant Type
  - 19.5.5. Sample Type
  - 19.5.6. Product Type
  - 19.5.7. End-User
  - 19.5.8. Testing Location
- 19.6. Rest of South America PCR Based Transplant Diagnostics Market
  - 19.6.1. Country Segmental Analysis
  - 19.6.2. Technology Type
  - 19.6.3. Application
  - 19.6.4. Transplant Type
  - 19.6.5. Sample Type
  - 19.6.6. Product Type
  - 19.6.7. End-User
  - 19.6.8. Testing Location
20. Key Players/ Company Profile
- 20.1. Abbott Laboratories
  - 20.1.1. Company Details/ Overview
  - 20.1.2. Company Financials
  - 20.1.3. Key Customers and Competitors
  - 20.1.4. Business/ Industry Portfolio
  - 20.1.5. Product Portfolio/ Specification Details
  - 20.1.6. Pricing Data
  - 20.1.7. Strategic Overview
  - 20.1.8. Recent Developments
- 20.2. Agilent Technologies
- 20.3. bioMérieux
- 20.4. Bio-Rad Laboratories
- 20.5. CareDx
- 20.6. Eurofins Scientific
- 20.7. GenDx
- 20.8. Genetix Biotech Asia
- 20.9. Histogenetics
- 20.10. Hologic
- 20.11. Illumina
- 20.12. Immucor
- 20.13. Integrated DNA Technologies (IDT)
- 20.14. Linkage Biosciences
- 20.15. Luminex Corporation
- 20.16. Natera
- 20.17. Olerup SSP
- 20.18. Promega Corporation
- 20.19. Qiagen
- 20.20. Roche Diagnostics
- 20.21. Takara Bio
- 20.22. Thermo Fisher Scientific
- 20.23. Other Key Players

Note* - This is just tentative list of players. While providing the report, we will cover more number of players based on their revenue and share for each geography

Get PDF

PRICING DETAILS

Single-User Upto 2 Users - [PDF + Excel Only]

USD 4150

Multi-User Upto 10 Users - [PDF + Excel + PPT]

USD 5950

Enterprise-User Company-wide - [Report Pack + Benchmark + 6M Update]

USD 7750

Related Report

Discount On Multiple Reports

Where did We Help Most?

Custom Market Research Services

We will customise the research for you, in case the report listed above does not meet your requirements.

Get 10% Free Customisation